PDUFA dates June 2023: FDA calendar and catalysts.
0 PDUFA dates fell in June 2023. The FDA calendar also recorded 32 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in June 2023
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
June 2023: other FDA decisions and filings
June 2023: dated readouts
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Jun 2023Month disclosed | — | ALZN | Topline readout | — | Positive | sec_s1 |
| Jun 2023Month disclosed | — | GMAB | Topline readout | — | Positive | SEC Form 10-K |
| Jun 2023Month disclosed | — | MLTX | Topline readout | — | Positive | SEC Form 10-K |
| Jun 2023Month disclosed | — | MLTX | Topline readout | moderate-to-severe HS | Met primary endpoint | SEC Form 10-Q |
| Jun 2023Month disclosed | Opdivo® (nivolumab) | SLS | Topline readout | — | Positive | sec_424b |
| Jun 2023Month disclosed | SCI-110 | SPRC | Topline readout | Alzheimer's disease and agitation | Positive | SEC Form 10-K |
| June 13, 2023 | lanifibranor (IVA337) | IVA | Topline readout | NAFLD and T2D | Positive | sec_424b |
| June 26, 2023 | EP-104 | EPRX | Topline readout | — | Positive | SEC 8-K Exhibit 99.1 |
| June 29, 2023 | IGALMI® (dexmedetomidine) | BTAIQ | Topline readout | — | Positive | SEC Form 10-Q |
June 2023: trial starts and primary completions
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Jun 2023Month disclosed | luvelta | STRO | Trial start | platinum-resistant ovarian cancer in June 2023 | Completed | SEC Form 10-Q |
| Jun 2023Month disclosed | XYNGARI | DRMA | Trial start | — | Completed | SEC Form 10-K |
| June 6, 2023 | urcosimod (OK-101) | OKYO | Trial start | — | Completed | sec_424b |
| June 13, 2023 | lanifibranor (IVA337) | IVA | Trial start | NAFLD and T2D | Completed | sec_424b |
| June 26, 2023 | IPH5201 | IPHA | Trial start | — | Completed | SEC Form 10-K |
| June 22, 2023 | LB-100 | NMAD | Trial start | — | Completed | SEC Form 10-Q |
| June 30, 2023 | imeroprubart (IMVT-1402) | IMVT | Trial start | — | Completed | SEC Form 10-Q |
Questions
What PDUFA dates are in June 2023?
0 PDUFA dates fell in June 2023. The FDA calendar also recorded 32 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.